Regeneron revenue beats estimates on strong sales of Eylea, COVID therapy

Go back to Regeneron revenue beats estimates on strong sales of Eylea, COVID therapy
Regeneron (NASDAQ: REGN) Delayed: 631.81 -1.09 (0.17%)
Previous Close $632.90    52 Week High $592.36 
Open $635.99    52 Week Low $325.35 
Day High $638.30    P/E 165.83 
Day Low $626.86    EPS $3.81 
Volume 734,523